Giftify (GIFT) announced a significant increase in gift card sales following its announcement of a smart savings program for GLP-1 diabetes and weight loss medications. CardCash.com, Giftify’s secondary gift card exchange platform, experienced an overall 916% week-over-week, w/w, increase in the face value of gift cards sold across major pharmacy retailers. This surge follows the Company’s recent announcement of innovative savings opportunities for consumers purchasing high-cost prescription medications such as Ozempic from Novo Nordisk (NVO) and Zepbound from Eli Lilly (LLY), in addition to increased consumer demand for seasonal cold and flu remedies and other winter health products.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on GIFT:
Questions or Comments about the article? Write to editor@tipranks.com